Innospec Inc. (NASDAQ:IOSP) Shares Sold by Sei Investments Co.

Sei Investments Co. lessened its stake in shares of Innospec Inc. (NASDAQ:IOSP) by 1.2% during the second quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 137,094 shares of the specialty chemicals company’s stock after selling 1,694 shares during the quarter. Sei Investments Co. owned about 0.55% of Innospec worth $16,943,000 at the end of the most recent reporting period.

Other large investors have also recently bought and sold shares of the company. TFO Wealth Partners LLC lifted its position in shares of Innospec by 29,800.0% in the fourth quarter. TFO Wealth Partners LLC now owns 299 shares of the specialty chemicals company’s stock valued at $37,000 after acquiring an additional 298 shares in the last quarter. DekaBank Deutsche Girozentrale acquired a new position in Innospec in the 1st quarter valued at about $66,000. CWM LLC lifted its holdings in Innospec by 239.6% in the 2nd quarter. CWM LLC now owns 635 shares of the specialty chemicals company’s stock valued at $78,000 after purchasing an additional 448 shares in the last quarter. Motco purchased a new position in Innospec in the 1st quarter valued at about $132,000. Finally, EntryPoint Capital LLC acquired a new stake in shares of Innospec during the 1st quarter worth about $147,000. Institutional investors and hedge funds own 96.64% of the company’s stock.

Innospec Stock Performance

Shares of IOSP opened at $113.81 on Friday. Innospec Inc. has a fifty-two week low of $95.69 and a fifty-two week high of $133.71. The company has a market capitalization of $2.84 billion, a PE ratio of 19.32 and a beta of 1.08. The stock has a fifty day moving average of $114.49 and a two-hundred day moving average of $121.45.

Innospec (NASDAQ:IOSP) last released its earnings results on Tuesday, August 6th. The specialty chemicals company reported $1.39 EPS for the quarter, beating the consensus estimate of $1.37 by $0.02. Innospec had a return on equity of 14.15% and a net margin of 7.90%. The firm had revenue of $435.00 million during the quarter, compared to analyst estimates of $468.73 million. During the same period in the prior year, the firm posted $1.28 earnings per share. The business’s quarterly revenue was down 9.5% compared to the same quarter last year. As a group, equities research analysts forecast that Innospec Inc. will post 5.95 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Separately, StockNews.com lowered shares of Innospec from a “strong-buy” rating to a “buy” rating in a research report on Thursday, August 8th.

Insider Activity

In other news, CFO Ian Cleminson sold 3,398 shares of the stock in a transaction dated Monday, August 26th. The shares were sold at an average price of $114.74, for a total transaction of $389,886.52. Following the transaction, the chief financial officer now directly owns 12,996 shares in the company, valued at approximately $1,491,161.04. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Corporate insiders own 1.52% of the company’s stock.

Innospec Company Profile

Innospec Inc develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally. The company's Fuel Specialties segment offers a range of specialty chemical products that are used as additives in additives in diesel, jet, marine, fuel oil and other fuels.